Ada Forsyth Institute, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Previously recorded as Forsyth Dental Infirmary for Children (to 2024)
2
Ending by 2030
Jun 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Apr 8, 2027The maintenance fee for Methods for increasing oral osteogenesis using lipoxin A4 (LXA4) and its analogs (US 10,434,080) comes due Apr 8, 2027. Unpaid by Oct 8, 2027, it lapses early.
- 1 fee due Jul 16, 2027The maintenance fee for Methods and compositions of preventing and treating dental caries (US 11,872,255) comes due Jul 16, 2027. Unpaid by Jan 18, 2028, it lapses early.
- 2 fees due Aug 13 to 20, 2027 · next Aug 13
Recent changes
- 1 term has ended since Aug 24, 2026
- Nov 17 US 9,968,577 Treatment and Prevention of Bone Loss Using Resolvins · term ended
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 9 of 9
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,021,148 | Intraoral light-emitting device In force (reinstated) · USPTO record | In force (reinstated) | USPTO record | |
| US 8,636,986 | Treatment and Prevention of Bone Loss Using Resolvins In force · High confidence | In force | High confidence | |
| US 9,376,686 | Vaccine and therapeutic delivery system In force · USPTO record | In force | USPTO record | |
| US 10,434,080 | Methods for increasing oral osteogenesis using lipoxin A4 (LXA4) and its analogs In force · USPTO record | In force | USPTO record | |
| US 11,896,571 | Methods for increasing oral osteogenesis using lipoxin A4 (LXA4) and its analogs In force · USPTO record | In force | USPTO record | |
| US 11,903,998 | Compositions and methods of treating cancer using lipid agonists and receptors thereof In force · USPTO record | In force | USPTO record | |
| US 11,246,895 | Methods and compositions of preventing and treating dental caries In force · USPTO record | In force | USPTO record | |
| US 11,872,255 | Methods and compositions of preventing and treating dental caries In force · USPTO record | In force | USPTO record | |
| US 12,708,271 | Method and System for Detecting Molar Incisor Hypomineralization Using High Resolution Raman Analyses of Tooth Composition In force · High confidence | In force | High confidence |
Also on record, not counted in the 9: 1 lapsed for an unpaid fee · 1 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 pending · 1 no status recorded